We are live on ! Find out more
Geode Capital Management

Geode Capital Management Portfolio holdings

AUM $1.61T
1-Year Est. Return 30.72%
 

Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.

This Fund
S&P 500
This Quarter Est. Return
+13.1%
1 Year Est. Return
+30.72%
3 Year Est. Return
+105.46%
5 Year Est. Return
+141.95%
10 Year Est. Return
+549.41%
AUM
$1.08T
AUM Growth
+$125B
Cap. Flow
+$32.6B
Cap. Flow %
3.01%
Top 10 Hldgs %
27.52%
Holding
4,738
New
85
Increased
3,720
Reduced
276
Closed
123

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$1.81B
2
MSFT icon
Microsoft
MSFT
+$1.34B
3
AAPL icon
Apple
AAPL
+$1.25B
4
AMZN icon
Amazon
AMZN
+$1.17B
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$480M

Top Sells

Rank Stock Value
1
SPLK
Splunk Inc
SPLK
+$373M
2
AMGN icon
Amgen
AMGN
+$204M
3
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
+$180M
4
IMGN
Immunogen Inc
IMGN
+$160M
5
SRC
SPIRIT REALTY CAPITAL, INC.
SRC
+$109M

Sector Composition

Rank Sector Weight
1 Technology 29.47%
2 Financials 12.91%
3 Healthcare 12.22%
4 Consumer Discretionary 10.6%
5 Industrials 9.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CNSP icon
4551
CNS Pharmaceuticals
CNSP
$8.02M
$10.2K ﹤0.01%
1
– –
NXU
4552
DELISTED
Nxu, Inc. Class A Common Stock
NXU
$10.2K ﹤0.01%
+750
New +$16.1K
FOXO
4553
DELISTED
FOXO TECHNOLOGIES INC A
FOXO
$10.1K ﹤0.01%
1,249
– –
AZ icon
4554
A2Z Smart Technologies
AZ
$268M
$9.9K ﹤0.01%
6,526
– –
OMH icon
4555
Ohmyhome Ltd
OMH
$3.03M
$9.71K ﹤0.01%
1,033
– –
LSB
4556
DELISTED
LakeShore Biopharma
LSB
$9.53K ﹤0.01%
1,361
– –
LUCY icon
4557
Innovative Eyewear
LUCY
$6.18M
$9.23K ﹤0.01%
1,691
– –
CMMB
4558
Chemomab Therapeutics
CMMB
$13M
$9.14K ﹤0.01%
2,934
– –
OTRK
4559
DELISTED
Ontrak
OTRK
$9.06K ﹤0.01%
1,192
– –
SLNA
4560
DELISTED
Selina Hospitality PLC Ordinary Shares
SLNA
$8.98K ﹤0.01%
60,296
– –
ISPC icon
4561
iSpecimen
ISPC
$3.15M
$8.93K ﹤0.01%
48
– –
BURU
4562
DELISTED
NUBURU INC
BURU
$8.7K ﹤0.01%
308
-14
-4% -$423
DCFC
4563
DELISTED
Tritium DCFC Limited Ordinary Shares
DCFC
$8.61K ﹤0.01%
769
– –
PPBT
4564
Purple Biotech
PPBT
$1.37M
$8.47K ﹤0.01%
63
– –
CNTG
4565
DELISTED
Centogene N.V. Common Shares
CNTG
$8.26K ﹤0.01%
11,156
– –
ONCO icon
4566
Onconetix
ONCO
$3.45M
– –
0
– –
MYSZ icon
4567
My Size
MYSZ
$1.83M
$7.96K ﹤0.01%
2,247
– –
GWAV icon
4568
Greenwave Technology Solutions
GWAV
$3.4M
$7.83K ﹤0.01%
4
– –
ATXI
4569
DELISTED
Avenue Therapeutics, Inc. Common Stock
ATXI
$7.69K ﹤0.01%
695
– –
TONX
4570
TON Strategy Co
TONX
$162M
$7.58K ﹤0.01%
143
– –
ELBM
4571
Electra Battery Materials
ELBM
$67.3M
$7.48K ﹤0.01%
4,032
– –
STBX
4572
DELISTED
Starbox Group Holdings Ltd. Class A Ordinary Shares
STBX
$7.33K ﹤0.01%
15
– –
THMO
4573
DELISTED
ThermoGenesis Holdings, Inc. Common Stock
THMO
$7.3K ﹤0.01%
10,284
-16
-0.2% -$11
ILLR
4574
Triller Group Inc
ILLR
$21.2M
$6.93K ﹤0.01%
780
– –
NBSE
4575
DELISTED
NeuBase Therapeutics, Inc. Common Stock
NBSE
$6.84K ﹤0.01%
15,482
– –
181 182
183
184 185

Similar funds

JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Geode Capital Management's Q1 2024 Portfolio in Review

As of Q1 2024, Geode Capital Management held 4,738 positions worth $1.08T, up 13% from $956B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Geode Capital Management deployed $32.6B of net new capital in Q1 2024, opening 85 new positions and adding to 3,720 existing holdings. Its largest new stake was Solventum: 2,733,775 shares worth $0.

By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 29% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Amgen, an estimated $204M trimmed.

  • Geode Capital Management's largest Q1 2024 buy was Solventum: 2,733,775 shares worth $0.
  • Geode Capital Management added most to NVIDIA in Q1 2024, an estimated $1.81B increase.
  • Geode Capital Management's biggest Q1 2024 reduction was Amgen, cutting an estimated $204M.
  • Geode Capital Management fully exited Splunk Inc in Q1 2024, selling an estimated $373M.
  • Geode Capital Management's ten largest holdings make up 28% of its $1.08T portfolio in Q1 2024.
  • Geode Capital Management opened 85 new positions and closed 123 in Q1 2024.
  • Geode Capital Management's portfolio value rose 13% quarter-over-quarter to $1.08T.

Based on Geode Capital Management's 13F filing for Q1 2024, filed 13 May 2024.